Harada H. Functional and mechanistic linkage betweenp53-deficiency to HIF-1-mediated
hypoxia signaling in cancers. The 43rd. MBSJ. 2020. On-line. Dec. 3. 2020.
Harada H. A link between activation of HIF-1 and defect in p53 in malignant
progression of cancers. International Seminar on Stress Medicine and Precision
Healthcare; from Hypoxia and DNA Damage Response to Therapeutic Intervention.
National Taiwan University. Taipei. Dec 30, 2019.
Harada H. Tumor hypoxia; its influences on malignant progression and therapy
resistance of cancer cells. Special Seminar in Kobe University Graduate
School of Medicine. Kobe. Oct. 9, 2019.
Harada H. A link between HIF-1 and defect in p53 under hypoxic stress.
Core Sumposium 1: Microenvironmental Stress, The 78th Annual Meeting of
Japanese Cancer Association. Kyoto. Sep. 26. 2019.
Harada H. Radioresistance of hypoxic tumor cells; Lessons from hypoxia
& HIF-1 biology and beyond. The 16th International Congress of Radiation
Research 2019 (ICRR2019). Manchester, UK. Aug 25-29. 2019.
Harada H. How can we overcome tumor radioresistance; lessons from hypoxia
biology. The 1st China-Japan Int'l Joint Sympojium on 4Rs. China. Oct.
31. 2017.
Harada H. Tumor hypoxia; an imaging and therapeutic target of interest
for innovative radiation therapy. The 3rd Bordeaux-Kyoto Symposium. Bordeaux.
Jun. 29. 2017.
Harada H. Function of the UCHL1-HIF-1 Axis in Distant Metastasis and Radioresistance
of Cancer Cells. International Symposium of Radiation Biology Center, Kyoto
University 2016. Kyoto. Sep. 1-2. 2016.
原田浩. 放射線生物学・最近の話題 -低酸素とがん幹細胞-. 日本放射線腫瘍学会(JASTRO)夏季セミナー. 名古屋. Aug 6-7. 2016.
Harada H. Radioresistance of Cancer Cells; Lessons from HIF-1 Biology.
Annual Meeting of Association for Radiation Research 2016. Leicester. UK.
Jun 27-29. 2016.
Harada H. Tumor Hypoxia; a Potent Inducer of Malignant Phenotypes and Radioresistance
of Cancer Cells. The 2nd KU RBC-CEA Joint Workshop. Kyoto. Apr 11-12. 2016.
原田浩. 低酸素バイオロジーで迫るがん細胞の放射線抵抗性獲得機構. 日本放射線影響学会評議員学術講演会. 東京. Mar 29. 2016.
原田浩. 低酸素バイオロジーへのいざない. 幹細胞・がん・エピゲノムに関する合同リトリート. 滋賀. Mar 7. 2016.
Harada H. Tumor Hypoxia; a Potent Inducer of Tumor Malignant Phenotypes.
International Symposium@The 4th Military Medical University. Xi'an. China.
Jan. 7. 2016.
原田浩. Importance of Hypoxic Niche; Lessons from Hypoxia and Cancer Biology.
Biochemistry and Molecular Biology 2015 (BMB2015). Kobe. Dec 2. 2015.
原田浩. Molecular Biology for the Advancement of Cancer Radiotherapy; in the
Past and the Future. 日本放射線腫瘍学会 第28回学術大会. 群馬. Nov. 19. 2015.
Harada H. Tumor Hypoxia, a Potent Inducer of Malignant Phenotypes of Cancer
Cells. 2nd IFOM-Kyoto University Joint International Symposium. Kyoto.
Oct 7. 2015.
Harada H. UCHL1 provides novel diagnostic and antimetastatic strategy due
to its deubiquitinating effect on HIF-1alpha. Hypoxia Meeting, Oxford.
Jul. 4. 2014.
Harada H. HIF-1 as a Rational Target for Cancer Therapy. University of
Oxford, Oxford Institute for Radiation Oncology Seminar. Oxford, UK. May
29, 2014.
Harada H. Importance of HIF-1 in Radiation Oncology. The University of
Oxford. Gray Institute for Radiation Oncology & Biology Seminar. Apr.
7. 2014.
Harada H. Metabolic Reprogramming of Cancer Cells; a Rational Target for
the Diagnosis and Treatment of Cancers. FIRST Joint International Symposium;
Overcoming Intractable Cancer-a new path to the future. Feb. 24. 2014.
Harada H. Molecular Mechanism behind Tumor Radioresistance; Lessons from
Hypoxia Biology. The 72nd Annual Meeting of the Japanese Cancer Association.
Symposium #22: Toward the Improvement of Radiotherapy: Applications from
the Molecular Biological Points of View. Oct 3-5. 2013.
Harada H. Molecular Mechanism behind Tumor Recurrence after Radiation Therapy;
Lessons from Hypoxia Biology. The 3rd Asian Congress of Radiation Research.
May 13. 2013.
Harada H. Cancer cells that acquire HIF-1 activity after radiation therapy
cause local tumor recurrence after radiation therapy. International Session:
Molecular imaging in cancer research and treatment. 第71回日本癌学会学術総会. Sep.
19. 2012.
原田浩. がん細胞の動きを捉える. 京都大学基礎物理学研究所主導研究会2012. Aug. 9. 2012.
Harada H. Function of Hypoxia-Inducible Factor 1 in Tumor Recurrence after
Radiation Therapy; Lessons from Hypoxia Biology. The 31st Sapporo International
Cancer Symposium. Jul. 23-24. 2012.
Harada H. Molecular Mechanism behind HIF-1-mediated Radioresistance and
Postirradiation Recurrence of Malignant Solid Tumors. 14th International
Congress of Radiation Research 2011. Warsaw. Aug. 27-Sep. 3. 2011.
Harada H. Hypoxia-inducible Factor 1 (HIF-1) in Tumor Radioresistance.
31th Sapporo International Cancer Symposium 2011. Sapporo. Jul. 11-12.
2011.(震災により延期になりました)
Harada H. Tracking the dynamics of hypoxic tumor cells during tumor growth
and after radiation therapy. The 1st International Symposium for Molecular-targeting
Radiation Therapy. Kyoto. Feb. 3-4. 2011.
原田浩. Function of HIF-1 in Local Tumor Recurrence after Radiation Therapy.
東北大学・加齢医学研究所セミナー. 仙台. Nov. 19. 2010.
原田浩. 低酸素がん細胞の腫瘍内動態解析 ~がんの再発メカニズムの解明~. 群馬大学Clinical Oncology Research研究会.
群馬大学. June 3. 2010
Harada H. Tracking the Dynamics of Hypoxic Tumor Cells during Local Tumor
Recurrence after Radiation Therapy. Fourth Military Medical University
Seminar. Xi’an, China. May 24. 2010.
Harada H. Peri-necrotic tumor cells cause recurrence after radiotherapy
through migration to tumor blood vessels. International Symposium/Retreat,
Kyoto University Global COE Program, Center for Frontier Medicine. Nov.
7. 2009.
Harada H. Optical Imaging of Tumor Hypoxia, Cell Cycle, pH, and DNA double
strand breaks to Analyze the Molecular Mechanism Underlying Tumor Radioresistance.
3rd International Symposium on Nanomedicine. Nov 4th. 2009.
原田浩. In vivo光イメージングによる“がんの放射線抵抗性機構”へのアプローチ. 徳島大学大学院ソシオテクノサイエンス研究部セミナー.
Oct. 29. 2009.
Harada H. Optical Imaging of Intratumoral HIF-1 Activity to Elucidate the
Mechanism Underlying HIF-1-mediated Tumor Radioresistance. Invited Seminar.
Gray Institute for Radiation Oncology & Biology, University of Oxford.
Oxford. United Kingdom. Sep. 25. 2009.
Harada H, Tumor Hypoxia: A Microenvironmental Target in Cancer Therapy.
Asian Association of Radiation Research (AARR) Award Session in 2nd Asian
Congress for Radiation Research (ACRR). Seoul, Korea. May 20th. 2009.
Harada H, Optical Imaging of Intratumoral HIF-1 Activity to Elucidate the
Mechanism Underlying HIF-1-mediated Tumor Radioresistance. Symposium #10
(Tumor Microenvironment) in 2nd Asian Congress for Radiation Research (ACRR).
Seoul, Korea. May 19th. 2009.
Harada H, Identification of the source of Tumor recurrence after radiation
therapy. Radiation Oncology Seminar in Seoul National University, Seoul.
May 18th. 2009.
Harada H, A Molecular Mechanism Underlying the HIF-1-mediated Radioresistance
of Solid Tumors. Massachusetts General Hospital (MGH) Special Seminar.
Harvard, Boston. Sep 20th. 2008.
原田浩. がん研究における生体イメージングの可能性 –“形態を観る”から“機能(病態)を診る”時代へのパラダイムシフト-. 住友化学ライフサイエンスセミナー.
大阪. Feb 28th 2008.
Harada H, Tumor Hypoxia and HIF-1. International Symposium for Cancer Therapy,
China-Japan Bilateral Seminar on Radiation Medicine from Bench to Clinic.
Xi’an, China. Nov 20th. 2007.
Harada H, Real-time Imaging of Tumor Hypoxia as HIF-1-dependent Bioluminescence
and Fluorescence. International Symposium for Cancer Therapy, Beijing,
China. 2007.
Harada H. Optical Imaging of HIF-1 activity in Tumor Xenografts. International
Crosscutting Symposium; Molecular Bio-imaging And 4D Image-guided Radiotherapy.
July 14th-16th 2006.